Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-6,284
Closed -$435K – 603
2023
Q4
$435K Buy
6,284
+494
+9% +$29.8K 0.01% 306
2023
Q3
$317K Sell
5,790
-356
-6% -$20.2K 0.01% 354
2023
Q2
$343K Buy
6,146
+148
+2% +$7.39K 0.01% 353
2023
Q1
$305K Buy
5,998
+431
+8% +$20.4K 0.01% 405
2022
Q4
$222K Buy
+5,567
New +$208K 0.01% 508
2020
Q3
– Sell
-418
Closed -$14K – 305
2020
Q2
$14K Buy
+418
New +$12.9K ﹤0.01% 467
2019
Q4
– Sell
-393
Closed -$14K – 631
2019
Q3
$14K Hold
393
– – ﹤0.01% 286
2019
Q2
$13K Buy
393
+101
+35% +$3.28K ﹤0.01% 267
2019
Q1
$9K Hold
292
– – ﹤0.01% 269
2018
Q4
$8K Buy
292
+97
+50% +$2.75K ﹤0.01% 259
2018
Q3
$6K Buy
+195
New +$6.56K ﹤0.01% 288
2015
Q4
– Sell
-265
Closed -$7K – 417
2015
Q3
$7K Buy
+265
New +$7.67K ﹤0.01% 382

Other funds holding CRH

Balentine LLC's CRH Position: Q1 2024 in Review

Balentine LLC sold out of CRH (CRH) in Q1 2024, closing a stake of 6,284 shares — an estimated $435K sold.

Balentine LLC first reported a position in CRH in Q3 2015 and held it in 12 quarters. The position peaked at $435K in Q4 2023. 651 funds tracked by Wall St. Rank hold CRH as of Q1 2024.

  • Balentine LLC reported no remaining CRH position as of Q1 2024 after selling out during the quarter.
  • Balentine LLC sold 6,284 CRH shares in Q1 2024, an estimated $435K.
  • Balentine LLC first reported a position in CRH in Q3 2015 and held it in 12 quarters.
  • Balentine LLC's CRH position peaked at $435K in Q4 2023.
  • 651 funds tracked by Wall St. Rank held CRH as of Q1 2024.

Based on Balentine LLC's 13F filing for Q1 2024, filed 15 May 2024.